Curebase, AppliedVR Announce Agreement to Run Multiple VR Therapy Clinical Trials
Excerpt from the Press Release:
SAN FRANCISCO and LOS ANGELES, Aug. 26, 2021 /PRNewswire/ — Curebase, a company committed to democratizing access to clinical studies, and AppliedVR, a pioneer advancing the next generation of digital medicine, today announced a one-year partnership where AppliedVR will deploy the Curebase platform to run five clinical trials assessing the effectiveness of virtual reality-based (VR) therapy to treat chronic pain.
AppliedVR is the most evidence-based therapeutic VR platform for pain management, and has been used by more than 30,000 patients in more than 240 of the top health systems globally. The clinical trials with Curebase will focus on studying a self-administered, at-home VR therapy program, with Curebase software managing online patient recruitment, consent, participant engagement, and collecting patient reported outcomes. The Curebase platform also will support clinical workflows, including randomization schema, research coordinator communication, PI oversight, and coordination of VR headset and trial kit distribution.
Click the button below to read the entire Press Release:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?